277 related articles for article (PubMed ID: 21045174)
1. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
[TBL] [Abstract][Full Text] [Related]
2. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet.
Silbernagel G; Kovarova M; Cegan A; Machann J; Schick F; Lehmann R; Häring HU; Stefan N; Schleicher E; Fritsche A; Peter A
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2288-92. PubMed ID: 23015656
[TBL] [Abstract][Full Text] [Related]
3. Stearoyl-CoA desaturase 1 coding sequences and antisense RNA affect lipid secretion in transfected chicken LMH hepatoma cells.
Diot C; Lefèvre P; Hervé C; Belloir B; Narce M; Damon M; Poisson JP; Mallard J; Douaire M
Arch Biochem Biophys; 2000 Aug; 380(2):243-50. PubMed ID: 10933878
[TBL] [Abstract][Full Text] [Related]
4. An integrative metabolism approach identifies stearoyl-CoA desaturase as a target for an arachidonate-enriched diet.
Mutch DM; Grigorov M; Berger A; Fay LB; Roberts MA; Watkins SM; Williamson G; German JB
FASEB J; 2005 Apr; 19(6):599-601. PubMed ID: 15670975
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
[TBL] [Abstract][Full Text] [Related]
6. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios.
Peter A; Cegan A; Wagner S; Lehmann R; Stefan N; Königsrainer A; Königsrainer I; Häring HU; Schleicher E
Clin Chem; 2009 Dec; 55(12):2113-20. PubMed ID: 19850634
[TBL] [Abstract][Full Text] [Related]
7. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
8. Hormonal regulation of stearoyl coenzyme-A desaturase 1 activity and gene expression in primary cultures of chicken hepatocytes.
Lefevre P; Diot C; Legrand P; Douaire M
Arch Biochem Biophys; 1999 Aug; 368(2):329-37. PubMed ID: 10441384
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver.
Kotronen A; Seppänen-Laakso T; Westerbacka J; Kiviluoto T; Arola J; Ruskeepää AL; Oresic M; Yki-Järvinen H
Diabetes; 2009 Jan; 58(1):203-8. PubMed ID: 18952834
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.
Mai K; Andres J; Bobbert T; Assmann A; Biedasek K; Diederich S; Graham I; Larson TR; Pfeiffer AF; Spranger J
Metabolism; 2012 Jan; 61(1):108-16. PubMed ID: 21741058
[TBL] [Abstract][Full Text] [Related]
11. Conjugated linoleic acid decreases hepatic stearoyl-CoA desaturase mRNA expression.
Lee KN; Pariza MW; Ntambi JM
Biochem Biophys Res Commun; 1998 Jul; 248(3):817-21. PubMed ID: 9704011
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase1 expression and enzyme activity.
Kang K; Miyazaki M; Ntambi JM; Pariza MW
Biochem Biophys Res Commun; 2004 Mar; 315(3):532-7. PubMed ID: 14975733
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel LC/MS method to quantitate cellular stearoyl-CoA desaturase activity.
Dillon R; Greig MJ; Bhat BG
Anal Chim Acta; 2008 Oct; 627(1):99-104. PubMed ID: 18790132
[TBL] [Abstract][Full Text] [Related]
14. SCD1 inhibition during 3T3-L1 adipocyte differentiation remodels triacylglycerol, diacylglycerol and phospholipid fatty acid composition.
Ralston JC; Mutch DM
Prostaglandins Leukot Essent Fatty Acids; 2015 Jul; 98():29-37. PubMed ID: 25959085
[TBL] [Abstract][Full Text] [Related]
15. Diacylglycerol acyltransferase 1, stearoyl-CoA desaturase 1, and sterol regulatory element binding protein 1 gene polymorphisms and milk fatty acid composition in Italian Brown cattle.
Conte G; Mele M; Chessa S; Castiglioni B; Serra A; Pagnacco G; Secchiari P
J Dairy Sci; 2010 Feb; 93(2):753-63. PubMed ID: 20105547
[TBL] [Abstract][Full Text] [Related]
16. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells.
Choi Y; Park Y; Pariza MW; Ntambi JM
Biochem Biophys Res Commun; 2001 Jun; 284(3):689-93. PubMed ID: 11396956
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of delta5-desaturase, delta6-desaturase, stearoyl-coenzyme A (CoA) desaturase 1, and stearoyl-CoA desaturase 2 in rat testis.
Saether T; Tran TN; Rootwelt H; Christophersen BO; Haugen TB
Biol Reprod; 2003 Jul; 69(1):117-24. PubMed ID: 12606372
[TBL] [Abstract][Full Text] [Related]
18. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism.
Stamatikos AD; Paton CM
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E767-75. PubMed ID: 23941875
[TBL] [Abstract][Full Text] [Related]
19. Diet-dependent alterations of hepatic Scd1 expression are accompanied by differences in promoter methylation.
Schwenk RW; Jonas W; Ernst SB; Kammel A; Jähnert M; Schürmann A
Horm Metab Res; 2013 Oct; 45(11):786-94. PubMed ID: 23803969
[TBL] [Abstract][Full Text] [Related]
20. Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis.
Lee JJ; Lambert JE; Hovhannisyan Y; Ramos-Roman MA; Trombold JR; Wagner DA; Parks EJ
Am J Clin Nutr; 2015 Jan; 101(1):34-43. PubMed ID: 25527748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
